1 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates


Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 12 février 2020
Doi : 10.1016/j.jaad.2019.12.034
Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States

Hasan Khosravi, MD a, , Sophia Zhang, BS b, Alyce M. Anderson, MD, PhD a, Laura K. Ferris, MD, PhD a, c, Sonal Choudhary, MD a, Timothy Patton, DO a
a Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania 
b University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 
c Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 

Correspondence to: Hasan Khosravi, MD, 3601 Fifth Ave, 5th Floor, Pittsburgh, PA 152133601 Fifth Ave5th FloorPittsburghPA15213

 Funding sources: None.
 Conflicts of interest: None disclosed.
 IRB approval status: Approved by University of Pittsburgh Institutional Review Board (STUDY19030023).
 Reprints not available from the authors.

Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline